Although the data for PCSK9 inhibitors is thus far reassuring, a more subtle effect cannot be excluded and it is notable that widespread acceptance of the link between statins and diabetes came only after large scale meta-analysis including thousands of new cases of diabetes. The gene discussed is PCSK9; the disease is diabetes mellitus.